Masaya Yamaga

The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study

Morito Mezawa, Minoru Takemoto, Shunichiro Onishi et al. · BioFactors · 2012 · 43 citations

Medicine, Endocrinology, Pharmacology +16

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)

Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi et al. · Diabetes Obesity and Metabolism · 2019 · 42 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME‐V study)

Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi et al. · Journal of Diabetes Investigation · 2020 · 26 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Pituitary Adenylate Cyclase-Activating Polypeptide Protects Glomerular Podocytes from Inflammatory Injuries

Kenichi Sakamoto, Kyoko Kuno, Minoru Takemoto et al. · Journal of Diabetes Research · 2015 · 21 citations · Full text

Medicine, Cell Biology, Pharmacology +17

Werner syndrome: a model for sarcopenia due to accelerated aging

Masaya Yamaga, Minoru Takemoto, Mayumi Shoji et al. · Aging · 2017 · 19 citations · Full text

Medicine, Geriatric Medicine, Radiology +17